Determination of VEGF and CXCR4 in Tumor and Peritumoral Tissue of Patients with Breast Cancer as a Predictive Factor
DOI:
https://doi.org/10.4108/eai.25-3-2022.173714Keywords:
Breast cancer, Peritumoral tissue, CXCR-4, VEGF, Predictive factorAbstract
INTRODUCTION: Despite the obvious progress in the field of diagnosis and therapy, further measures are needed to increase the effectiveness of treatment and reduce morbidity and mortality from breast cancer.
OBJECTIVES: To study the influence of peritumoral tissue on the growth and development of the tumor itself.
METHODS: An immunofluorescence method was used to determine the protein expression of VEGF and CXCR-4 in tumor and peritumoral tissue.
RESULTS: Peritumoral tissue is not only a passive factor, but actively participates in the process of tumor growth and development, as well as in the processes of recurrence and metastasis.
CONCLUSION: Markers of neoangiogenesis in tumor and peritumoral tissue such as protein expression of VEGF and CXCR-4 receptors may serve as reliable predictors of disease outcome in breast cancer patients, which may provide useful suggestions in treatment choices.
Downloads
Published
How to Cite
Issue
Section
License
This is an open-access article distributed under the terms of the Creative Commons Attribution CC BY 3.0 license, which permits unlimited use, distribution, and reproduction in any medium so long as the original work is properly cited.